Kamada

KMDA NASDAQ
5.92
-0.02
-0.34%
Opening 15:02 07/22 EDT
Open
5.99
Prev Close
5.94
High
5.99
Low
5.90
Volume
20.57K
Avg Vol (3M)
48.25K
52 Week High
6.70
52 Week Low
4.633
% Turnover
0.05%
Market Cap
238.55M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Kamada KMDA stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Kamada Ltd. is an Israel-based biopharmaceutical company, which develops, produces and markets therapeutics, based on chromatographic purification technology. It offers bio-therapeutics for human use, such as specialty proteins, specific immunoglobulins, and other prescription medicines. The Company’s product line includes intravenous AAT for chronic replacement therapy in individuals with congenital alpha-1 antitrypsin deficiency; KamRAB for prophylaxis of rabies infection; KamRho-D IM for prophylaxis of Rh hemolytic disease of the newborn; KamRho-D IV for treatment of immune thrombocytopenic purpura; and IVIG, a replacement therapy in primary and secondary immune therapy. Its product line also comprises Protosol to reduce blood loss in patients undergoing cardiac surgery; Heparin sodium injection for coagulation inhibition and prophylaxis of thromboembolic diseases and Heparin Lock Flush to maintain potency of intravenous injection device among other.
MORE >

Recently

Name
Price
%Change